171 related articles for article (PubMed ID: 11562571)
1. Progress in Guillain-Barré syndrome.
Hartung HP; Kieseier BC; Kiefer R
Curr Opin Neurol; 2001 Oct; 14(5):597-604. PubMed ID: 11562571
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of axonal Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
[TBL] [Abstract][Full Text] [Related]
3. Guillain-Barré syndrome following hepatitis E.
Loly JP; Rikir E; Seivert M; Legros E; Defrance P; Belaiche J; Moonen G; Delwaide J
World J Gastroenterol; 2009 Apr; 15(13):1645-7. PubMed ID: 19340910
[TBL] [Abstract][Full Text] [Related]
4. The Guillain-Barré syndrome: a true case of molecular mimicry.
Ang CW; Jacobs BC; Laman JD
Trends Immunol; 2004 Feb; 25(2):61-6. PubMed ID: 15102364
[TBL] [Abstract][Full Text] [Related]
5. [Molecular Mimicry and Guillain-Barré Syndrome].
Yuki N
Brain Nerve; 2015 Nov; 67(11):1341-6. PubMed ID: 26560949
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.
Asthana P; Vong JS; Kumar G; Chang RC; Zhang G; Sheikh KA; Ma CH
Mol Neurobiol; 2016 Sep; 53(7):4981-91. PubMed ID: 26374552
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment.
Jasti AK; Selmi C; Sarmiento-Monroy JC; Vega DA; Anaya JM; Gershwin ME
Expert Rev Clin Immunol; 2016 Nov; 12(11):1175-1189. PubMed ID: 27292311
[TBL] [Abstract][Full Text] [Related]
9. A family with Campylobacter enteritis: anti-GD1a antibody with/without Guillain-Barré syndrome.
Hirano M; Kusunoki S; Asai H; Tonomura Y; Morita D; Ueno S
Neurology; 2003 May; 60(10):1719-20. PubMed ID: 12771281
[No Abstract] [Full Text] [Related]
10. [Guillain-Barré syndrome: immunopathology, update].
Chiba A
Nihon Rinsho; 2008 Jun; 66(6):1184-9. PubMed ID: 18540368
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
[TBL] [Abstract][Full Text] [Related]
12. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
[TBL] [Abstract][Full Text] [Related]
13. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
[TBL] [Abstract][Full Text] [Related]
14. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions.
Shahrizaila N; Yuki N
Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076
[TBL] [Abstract][Full Text] [Related]
15. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barré syndrome?
Berciano J; Illa I
Neurology; 2005 Feb; 64(4):766-7; author reply 766-7. PubMed ID: 15728323
[No Abstract] [Full Text] [Related]
16. New concepts of Guillain-Barré syndrome.
Asbury AK
J Child Neurol; 2000 Mar; 15(3):183-91. PubMed ID: 10757475
[TBL] [Abstract][Full Text] [Related]
17. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
Eldar AH; Chapman J
Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
[TBL] [Abstract][Full Text] [Related]
18. Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barré syndrome.
Koga M; Yuki N; Hirata K; Morimatsu M; Mori M; Kuwabara S
Neurology; 2003 May; 60(9):1514-8. PubMed ID: 12743241
[TBL] [Abstract][Full Text] [Related]
19. Demyelinating motor Guillain-Barré syndrome following rubella.
Capasso M; Di Muzio A; Caporale CM; De Angelis MV; Lugaresi A; Uncini A
Neurology; 2005 Jan; 64(2):390. PubMed ID: 15668453
[No Abstract] [Full Text] [Related]
20. Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome.
van Sorge NM; van der Pol WL; Jansen MD; van den Berg LH
Autoimmun Rev; 2004 Feb; 3(2):61-8. PubMed ID: 15003189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
